Summary
The Niemann-Pick type C is a rare metabolic disease with a severe neurodegenerative phenotype characterized by an accumulation of high amounts of lipids (cholesterol and sphingolipids) in the late endosomal/lysosomal network. It is caused by loss-of-function point mutations in either NPC1 or NPC2, which seem to mediate proper intracellular lipid transport through endocytic pathway. In this study, we show that yeast cells lacking Ncr1p, an orthologue of mammalian NPC1, exhibited a higher sensitivity to hydrogen peroxide and a shortened chronological lifespan. These phenotypes were associated with increased levels of oxidative stress markers, decreased levels of antioxidant defenses and mitochondrial dysfunctions. Moreover, we report that Ncr1p deficient cells displayed high levels of long chain bases (LCB), and that Sch9p-phospho-T570 and Sch9p levels increased in ncr1Δ cells through a mechanism regulated by Pkh1p, a LCB-activated protein kinase. Notably, deletion of PKH1 or SCH9 suppressed ncr1Δ phenotypes but downregulation of de novo sphingolipid biosynthesis had no protective effect, suggesting that LCBs accumulation may result from an increased turnover of complex sphingolipids. These results suggest that sphingolipid signaling through Pkh1p-Sch9p mediate mitochondrial dysfunction, oxidative stress sensitivity and shortened chronological lifespan in the yeast model of Niemann-Pick type C disease.
Keywords: Niemann-Pick type C, sphingolipid signaling, mitochondria, lifespan, Pkh1p, Sch9p
Introduction
Niemann-Pick type C (NPC) disease is an autosomal recessive neurodegenerative disorder, with cellular lipid trafficking defects, involving more specifically low-density-lipoprotein derived cholesterol (Pentchev et al., 1994), and is characterized by progressive neurological deterioration with general symptoms of splenomegaly and dementia (Vanier, 2010). Besides cholesterol sequestration, NPC cells can also accumulate other lipids such as gangliosides and sphingolipids (Vanier, 1999) including sphingosine (Lloyd-Evans et al., 2008). NPC is caused by loss-of-function point mutations in either NPC1 that accounts for 95 % of the cases (Carstea et al., 1997) or NPC2 (Naureckiene et al., 2000). The NPC1 protein is a large transmembrane protein that is located in the transient late endosome/lysosome system, while NPC2 protein is a soluble glycoprotein with high affinity for cholesterol (Vanier & Millat, 2004, Ko et al., 2003). Both proteins seem to be involved in intracellular transport of endocytosed cholesterol through the endolysosomal system (Kwon et al., 2009). Since the deficiency in NPC1 or NPC2 results in similar phenotypes and cellular lesions (Walkley & Suzuki, 2004, Sleat et al., 2004), it has been suggested that both proteins function sequentially in the same pathway. However, the exact function of each protein and the molecular mechanisms associated with NPC disease remain poorly characterized.
Several pieces of evidence suggest that oxidative stress is associated with NPC pathophysiology (Vazquez et al., 2012). These include changes in the expression of antioxidant defenses in NPC fibroblasts (Reddy et al., 2006), NPC hepatocytes (Vazquez et al., 2011), and NPC1 cerebellum (Cologna et al., 2012), higher levels of reactive oxygen species and accumulation of oxidized lipids (Zampieri et al., 2009) and proteins (Vazquez et al., 2011). Oxidative stress is tightly linked to mitochondrial dysfunction, either because mitochondria are a generator or a target of reactive oxygen species (ROS) (Murphy, 2009). NPC cells present mitochondrial dysfunctions that have been associated with the accumulation of cholesterol in mitochondria of NPC neurons and hepatocytes (Yu et al., 2005, Ikonen & Holtta-Vuori, 2004, Charman et al., 2010). Changes in calcium homeostasis may also contribute to mitochondrial dysfunctions, since NPC cells exhibit defects in lysosomal Ca2+ uptake and NAADP-mediated lysosomal Ca2+ release (Lloyd-Evans & Platt, 2011). It was recently shown that δ-tocopherol, a minor vitamin E species, reduces cholesterol accumulation in NPC1 cells by enhancing lysosomal exocytosis associated with an increase of intracellular calcium concentration and amelioration of lysosomal calcium deficiency (Xu et al., 2012). Moreover, the accumulation of sphingomyelin in the lysosome lumen inhibits TRPML1-mediated lysosomal Ca2+ release, blocking Ca2+-dependent membrane trafficking (Shen et al., 2012).
NPC1 and NPC2 are conserved from yeast to humans (Berger et al., 2005b, Berger et al., 2005a) and Saccharomyces cerevisiae has been used as a model system to study the cellular and molecular consequences of NPC deficiency. There is 35 % amino acid sequence identity between NPC1 and Ncr1p, and the expression of Ncr1p in NPC1 deficient cells suppresses cholesterol and ganglioside accumulation (Malathi et al., 2004). Moreover, both proteins reside in the membrane of the lysosomal (vacuolar in yeast)/endosomal systems (Zhang et al., 2004, Berger et al., 2005a). A recent study identified 12 pathways and 13 genes required for growth of Ncr1p deficient cells under anaerobiosis, a sterol auxotrophy condition, and showed that histone deacetylase inhibition corrects for cholesterol and sphingolipid transport defects in human NPC disease (Munkacsi et al., 2011). Thus, yeast is a powerful model system that can be used to identify new targets for pharmacological intervention in NPC disease. A large-scale comparison of yeast deletion strains also showed that NCR1 deleted cells exhibit a shortened chronological lifespan (Laschober et al., 2010).
Sphingolipids are ubiquitous structural components of eukaryotic cell membranes and function as signaling molecules for regulating proliferation, mitogenesis, cell migration, apoptosis, cell senescence and inflammation (Hannun & Obeid, 2008). As mentioned above, the accumulation of the long chain sphingoid base (LCB) sphingosine has been implicated in NPC disease (Lloyd-Evans et al., 2008). In yeast, LCB activate the Pkh1/2p protein kinases, homologues of mammalian phosphoinositide-dependent protein kinase 1 (PDK1), which then phosphorylate a T570 residue in the activation loop of Sch9p, a homologue of mammalian ribosomal S6 kinase also related to mammalian Akt/protein kinase B (Roelants et al., 2004, Liu et al., 2005, Voordeckers et al., 2011). In vitro studies suggest that Sch9p also can be activated by PHS through a Pkh1p-independent mechanism (Liu et al., 2005). Sch9p is also phosphorylated in the C terminus by the target of rapamycin complex 1 (TORC1; Urban et al., 2007). The Sch9p kinase is involved in modulation of mitochondrial function (Lavoie & Whiteway, 2008, Pan & Shadel, 2009), entry and exit from stationary phase (Pedruzzi et al., 2003, Martinez et al., 2004), nutrient changes adaptation (Roosen et al., 2005), redox homeostasis and chronological lifespan (Fabrizio et al., 2001) although its downstream effectors are not fully characterized.
In this study, we show that ncr1Δ cells exhibit mitochondrial fragmentation/dysfunction, oxidative stress sensitivity and shortened CLS associated with the accumulation of LCBs. Moreover, we report that sphingolipid signaling through Pkh1p-Sch9p contributes to ncr1Δ phenotypes.
Results
ncr1Δ cells exhibit hydrogen peroxide sensitivity and shortened chronological lifespan associated with oxidative stress markers
The yeast model of NPC disease was generated by deletion of NCR1 gene in the S. cerevisiae BY4741 strain. Staining of yeast cells with filipin confirmed the accumulation of high levels of intracellular ergosterol in ncr1Δ cells (Supplemental Fig. S1; Brett et al., 2011), a cell membrane sterol found in fungi that serves the same functions as cholesterol in mammalian cells. This is consistent with the hallmark of NPC disease, namely cholesterol accumulation due to lipid trafficking defects (Pentchev et al., 1994).
Since oxidative stress has been associated with NPC pathophysiology (Vazquez et al., 2012), we examined cellular viability, the accumulation of oxidative damages and intracellular oxidation in S. cerevisiae BY4741 (parental strain) and ncr1Δ cells grown to exponential phase and exposed to 1.5 mM H2O2 during 1 h. The results show that ncr1Δ cells were significantly more sensitive to H2O2 than parental cells (Fig. 1A): 9% of ncr1Δ cells remained viable whereas 24% of wild-type cells survived. In agreement, H2O2-induced oxidative stress markers were significantly higher in ncr1Δ cells when compared to parental cells: protein oxidation increased 7.5-fold in ncr1Δ cells and 4-fold in parental cells (Fig. 1B); lipid peroxidation increased 2.5-fold in ncr1Δ cells but no significant changes were observed in parental cells (Fig. 1C); the % of ROS positive cells was 47% for ncr1Δ mutants and 24% for the parental strain (Fig. 1D). Notably, basal ROS levels were 3.5-fold higher in ncr1Δ cells when compared to parental cells. These results suggest that Ncr1p deficiency confers a higher sensitivity to hydrogen peroxide associated with an increased accumulation of oxidative stress markers.
Oxidative stress induced by endogenous factors, such as mitochondrial dysfunctions, has been associated with the progressive loss of cellular functions and viability during aging (Longo et al., 2012). Thus, we also investigated the effect of Ncr1p deficiency on yeast chronological lifespan (CLS), which is assessed by following the survival of non-dividing cells over time. This assay is a well-established cell model to study aging of post-mitotic cells (Fabrizio & Longo, 2003). Yeast cells were grown to stationary phase and kept in the growth medium over time. Cells lacking Ncr1p exhibited a shortened CLS, as shown by an accelerated loss of viability (Fig. 2A): in cells aged for 2 and 4 days, the viability of ncr1Δ mutants (55% and 13%, respectively) was significantly lower than that of parental cells (>93%). The premature aging and oxidative stress sensitivity of cells lacking Ncr1p were also observed in the W303a strain background (Supplementary Fig. S2), suggesting that ncr1Δ phenotypes are not strain specific.
The analysis of intracellular oxidation at post-diauxic shift phase (PDS; respiration-adapted cells), using the molecular probe dihydrorhodamine 123 that becomes fluorescent upon oxidation by hydrogen peroxide (Henderson & Chappell, 1993), shows that, compared with parental cells, Ncr1p deficient cells accumulated higher levels of ROS (Fig. 2B). Consistently, ncr1Δ mutant cells presented higher levels of protein carbonylation and lipid peroxidation (Fig. 2C–D). Aiming to assess if the accumulation of oxidative damages in Ncr1p deficient cells was correlated with defects in antioxidant defenses, we measured the activity of superoxide dismutase and catalase, which have important roles in the elimination of superoxide radicals and H2O2, respectively, as well as the levels of glutathione, a major non enzymatic antioxidant defense (Farrugia & Balzan, 2012). The results show that, although total superoxide dismutase (Sod) activity was similar in parental (BY4741) and ncr1Δ cells (Fig. 3A), the activity of the mitochondrial Sod (Sod2p or Mn-Sod) was significantly reduced in ncr1Δ cells (Fig. 3C). In addition, ncr1Δ cells presented lower levels of cytosolic catalase T (Ctt1p) activity (Fig. 3B, D) and glutathione (Fig. 3E), which is consistent with H2O2 accumulation in these mutants. It is well established that yeast are able to sense reactive oxygen species and to activate transcription factors, including Yap1p, Skn7p and Msn2/4p, that enhance the expression of genes associated with antioxidant defenses (de la Torre-Ruiz et al., 2010). Thus, our results suggest that Ncr1p deficiency seems to impair this adaptive response. Interestingly, the overexpression of SOD2 or CTT1 was not sufficient to increase chronological lifespan in ncr1Δ cells (Supplementary Fig. S4), suggesting that the accumulation of oxidative damages is probably a consequence rather than the cause for the premature aging of Ncr1p deficient cells.
ncr1Δ cells exhibit mitochondrial dysfunctions
The high levels of ROS and the lower activity of Sod2p displayed by ncr1Δ cells led us to postulate that this mutant presents mitochondrial dysfunctions. To test this hypothesis, we measured oxygen consumption, cytochrome c oxidase (COX) activity, porin levels and the capacity of the cells to grow on a non-fermentable carbon source (glycerol), which requires functional mitochondria. In parental cells, oxygen consumption rate increased during growth from exponential to PDS phase (Fig. 4A), which is consistent with the catabolic derepression and induction of mitochondrial activity associated with the transition from fermentative to respiratory metabolism (Santangelo, 2006). The COX activity was very low at the exponential phase (data not shown), being highly induced in PDS phase cells. Notably, oxygen consumption rate and COX activity were significantly lower in Ncr1p deficient cells (Fig. 4A–B) and these mutants were unable to grow on a non-fermentable (respiratory) carbon source (Fig. 4D). The levels of porin, another mitochondrial protein, decreased only 40% in ncr1Δ cells grown to PDS phase (Fig. 4C). These results suggest that the very low activities of COX and Sod2p may result in part from a decreased mitochondrial mass but also from the loss of function of these enzymes in ncr1Δ mutants. To get further insights into changes in mitochondrial function, we assessed the mitochondrial membrane potential (Δψm) by labeling parental and ncr1Δ cells with a mitochondria-specific voltage-dependent dye, DiOC6(3), which aggregates and preferentially accumulates into functional mitochondria. When the mitochondrial membrane depolarizes, the dye no longer accumulates in mitochondria and becomes distributed throughout the cell, resulting in a decrease in green fluorescence (Rottenberg & Wu, 1998). Our results show that cells lacking Ncr1p presented a significant drop in Δψm (Fig. 4E), indicating an increase in mitochondrial depolarization. The integrity of the mitochondrial network was also assessed by fluorescence microscopy using cells expressing a mitochondria-targeted DsRed protein. The parental cells grown to the PDS phase exhibited a normal mitochondrial tubular network. However, loss of Ncr1p led to the formation of a punctuate pattern indicative of mitochondrial network fragmentation (Fig. 4F). The overall results suggest that ncr1Δ mutant cells exhibit severe mitochondrial dysfunction after the PDS.
The Pkh1p-Sch9p pathway is involved in oxidative stress sensitivity, premature aging and mitochondrial dysfunctions of ncr1Δ cells
Lloyd-Evans et al. showed that, in addition to cholesterol, NPC cells accumulate sphingosine (Lloyd-Evans et al., 2008). This led us to postulate that similar changes in sphingolipid species occur in Ncr1p deficient cells and that sphingolipid signaling probably is associated with ncr1Δ phenotypes. We analyzed the levels of long chain sphingoid bases (dihydrosphingosine (DHS), phytosphingosine (PHS) and their 1-phosphate forms) in parental and ncr1Δ cells at the exponential (fermentative) and PDS (respiratory) phases (Fig. 5A–D).
The parental strain showed increasing levels of PHS (1.7-fold) and PHS-1-P (2.2-fold) in cells grown from exponential to PDS phase, but DHS and DHS-1-P decreased 2.4- and 4.1-fold, respectively. The deletion of NCR1 increased the basal levels of DHS-1-P (3.9-fold) and PHS-1-P (2.6-fold) in exponential phase cells, leading to higher ratios of DHS-1-P/DHS (3.1-fold) and PHS-1-P/PHS (1.8-fold). However, in the PDS phase, ncr1Δ cells exhibited higher levels of DHS (2.6-fold) and PHS (1.9-fold) and a lower DHS-1-P/DHS ratio (1.8-fold), compared with parental cells. This lipidomic analysis showed that the accumulation of LCBs displayed by NPC cells (Lloyd-Evans et al., 2008) is conserved in yeast ncr1Δ cells.
LCBs are known activators of the Pkh1p and Pkh2p protein kinases (Liu et al., 2005) that activate the Sch9p kinase by phosphorylating a T570 residue (Roelants et al., 2004, Voordeckers et al., 2011). Thus, we postulated that accumulation of LCBs mediates ncr1Δ phenotypes via modulation of a Pkh1p-Sch9p cascade. To characterize changes in this pathway associated with NCR1 deletion, the phosphorylation of Sch9p-T570 was analyzed by Western blotting. The ncr1Δ cells showed significantly higher levels of Sch9p-phospho-T570 (1.9-fold), concomitantly with a proportional increase of Sch9p expression (2-fold) (Fig. 6A). These results suggest that changes in Sch9p occur mainly at protein level. Nevertheless, the increase in the levels of both Sch9p and Sch9p-phospho-T570 was significantly attenuated in ncr1Δpkh1Δ double mutants indicating that it is mediated by Pkh1p-dependent mechanisms.
Next, we assessed the effect of PKH1 and SCH9 disruption on ncr1Δ cells. The pkh1Δ and sch9Δ cells exhibited a CLS and hydrogen peroxide resistance similar or slightly higher to that of parental cells, respectively (Fig. 6B–C). Other groups reported that SCH9 deletion significantly increases oxidative stress resistance and lifespan (Fabrizio et al., 2001) in contrast with the very small protective effect observed in the present study. This probably results from differences in the growth medium composition, in particular amino acid concentration. Indeed, it was recently shown that sch9Δ mutants exhibit an increased lifespan when cells are grown in media supplemented with a 3.5-fold excess of amino acids but have even shorter lifespan than parental cells when they are grown in media with 0.5X amino acids (Wu et al., 2013). Most importantly, the hydrogen peroxide sensitivity and shortened CLS of ncr1Δ cells was suppressed when PKH1 or SCH9 were disrupted in ncr1Δ cells (Fig. 6B–C). The defective cell growth on glycerol plates, decreased oxygen consumption, mitochondrial depolarization and mitochondrial network fragmentation displayed by ncr1Δ cells were also suppressed in both ncr1Δpkh1Δ and ncr1Δsch9Δ double mutants (Fig. 7A–D).
It was recently shown that downregulation of sphingolipid synthesis with myriocin, an inhibitor of serine palmitoyltransferase, increases yeast CLS in part due to a reduction of the Pkh1p-Sch9p activity (Huang et al., 2012). Thus, we also investigated the effect of myriocin on the CLS of ncr1Δ cells. Our results show that myriocin increased the lifespan of parental cells, but not of ncr1Δ mutants (Fig. 6D). This suggests that LCB accumulation may result from an increased turnover of complex sphingolipids and not from de novo biosynthesis. Nevertheless, the hypothesis that LCB-independent Sch9p functions also contribute to the shortened CLS of ncr1Δ cells cannot be excluded.
SCH9 deletion attenuates changes in sphingolipid homeostasis of ncr1Δ cells
We also investigated if the suppression of ncr1Δ phenotypes upon SCH9 deletion was associated with the modulation of sphingolipid homeostasis. Regarding LCBs (Fig. 5A–D), sch9Δ single mutants did not exhibit major changes in either exponential or PDS phase. However, the high levels of DHS and PHS exhibited by ncr1Δ cells grown to PDS phase were suppressed in ncr1Δsch9Δ cells. The overall data suggests that Sch9p mediates changes in sphingolipid metabolism associated with Ncr1p deficiency.
Discussion
The NPC disease represents the most common cause of childhood neurodegeneration. It has been intensively studied in the last years, mostly because it shares key features with emerging neurodegenerative disorders such as Alzheimer and Parkinson (Liu et al., 2010). Therefore, it is hoped that a comprehensive characterization of the molecular basis of lysosomal storage diseases will contribute to the understanding of the signaling pathways and regulatory mechanisms underlying these diseases, therefore opening new avenues for therapeutic interventions. The only therapeutic agent approved in Europe for NPC disease is miglustat, a reversible inhibitor of glycosphingolipid synthesis (Wraith & Imrie, 2009), which ameliorates some neurological symptoms (Pineda et al., 2010).
Yeast mutants lacking Ncr1p, the yeast orthologue of mammalian NPC1, have been used as an important model system to elucidate molecular mechanisms underlying the pathophysiology of NPC disease. Ncr1p is a vacuolar membrane protein that transits through the biosynthetic vacuolar protein sorting pathway, but it does not have an essential role in endocytic transport (Berger et al., 2005a, Zhang et al., 2004). Deletion of NCR1 leads to resistance to the ether lipid cytotoxic drug, edelfosine, which is not suppressed in ncr1Δ cells expressing Ncr1p carrying amino acid changes corresponding to human NPC1 patient mutations (Berger et al., 2005a, Zhang et al., 2004). Munkacsi et al. have recently shown that the deletion of components of the yeast NuA4 histone acetyltransferase complex in ncr1Δ cells confers anaerobic inviability and accumulation of multiple sterol intermediates, and that the inhibition of histone deacetylase corrects for cholesterol and sphingolipid transport defects in human NPC disease (Munkacsi et al., 2011). In this report we show that ncr1Δ cells were hypersensitive to oxidative stress induced by hydrogen peroxide, exhibiting higher levels of oxidative stress markers, namely protein carbonylation, lipid peroxidation and ROS. Similar features were observed in NPC1 cells (Zampieri et al., 2009) and in hepatocytes of NPC mice (Vazquez et al., 2011).
Resistance to oxidative stress has been correlated with longevity in numerous eukaryotic model systems, including yeast (Fabrizio & Longo, 2003, Pan, 2011). Our results show that ncr1Δ cells also displayed a premature aging phenotype associated with prominent changes in redox homeostasis and oxidative stress responses during the transition from fermentative to respiratory metabolism. Indeed, ncr1Δ cells at the PDS phase exhibited higher levels of intracellular ROS and of oxidized proteins and lipids. In addition, antioxidant defense systems were significantly compromised in ncr1Δ cells, namely glutathione, a low molecular weight non-protein thiol with a major role in the regulation of redox homeostasis and ROS scavenging (Costa & Moradas-Ferreira, 2001), as well as the mitochondrial superoxide dismutase (Sod2p) and the cytosolic catalase T (Ctt1p) which catalyze the dismutation of superoxide radicals into hydrogen peroxide and the decomposition of hydrogen peroxide, respectively. The activity of Sod1p, the superoxide dismutase present in the cytosol and in the mitochondrial intermembrane space, was not affected in ncr1Δ cells. In contrast, it was recently shown that SOD1 (Cu, Zn-superoxide dismutase) and CCS (copper chaperone for SOD1) gene expression are down regulated in hepatocytes of NPC mice (Vazquez et al., 2011) whereas SOD1 increases in NPC1 cerebellum (Cologna et al., 2012). Similarly to ncr1Δ yeast cells, a decrease in catalase activity was described in multiple organs of a mouse model of NPC (Schedin et al., 1997) and in fibroblasts collected from patients (Zampieri et al., 2009). Yet, the overexpression of SOD2 or CTT1 did not reverse the premature aging phenotype of ncr1Δ cells, suggesting that the accumulation of oxidative damages in Ncr1p deficient cells is an effect rather than the cause for its shortened chronological lifespan.
Our data suggest that the increased ROS levels leading to the accumulation of oxidative damage in ncr1Δ cells result from mitochondrial dysfunction. Yeast ncr1Δ cells were unable to grow on a non-fermentable carbon source (which requires functional mitochondria) and presented a decrease in COX activity and oxygen consumption. The levels of porin were 40% lower in ncr1Δ cells, suggesting that mitochondrial mass decreased in the mutant strain, with this effect accounting for the reduction of COX and Sod2p activities. However, the very low activity of these enzymes suggests that other cellular changes contribute to their loss of function. Previous studies have associated NPC with an impaired homeostasis of metals such as iron and copper (Reddy et al., 2006, De Windt et al., 2007, Vazquez et al., 2011, Goez et al., 2011). This may explain the decreased activity of COX, Sod2p as well as Ctt1p, since all these proteins are metal-dependent enzymes, but further studies are required to test this hypothesis. Consistent with mitochondrial dysfunctions, Ncr1p deficient cells also presented fragmentation of the mitochondrial network and mitochondrial depolarization. Cholesterol accumulation within the mitochondrial membranes of NPC1 mouse brains and neurons has been implicated in fluidity changes and in the decrease of mitochondrial membrane potential and ATP production (Yu et al., 2005). Mitochondrial fragmentation was also recently described in a stem-cell derived neuronal model of NPC (Ordonez et al., 2012).
Importantly, ncr1Δ cells showed high levels of LCBs thereby providing evidence that the accumulation of sphingosine previously implicated in NPC (Lloyd-Evans et al., 2008) is conserved in the yeast model of this disease. Our findings also implicate sphingolipid signaling in ncr1Δ phenotypes. In yeast, LCBs function in cell signaling through activation of the Pkh1/2p protein kinases that are homologues of mammalian PDK1 (Liu et al., 2005). One of the Pkh1p protein targets is the Sch9p protein kinase (Roelants et al., 2004, Liu et al., 2005, Voordeckers et al., 2011), a homologue of mammalian ribosomal S6 kinase that controls stress responses and lifespan (Longo, 2003, Lavoie & Whiteway, 2008, Pan & Shadel, 2009). Huang et al. have recently shown that down-regulating sphingolipid synthesis increases yeast lifespan in part due to a reduction in Sch9p activity and proposed that Sch9p regulates lifespan by integrating nutrient signals from TOR1 with growth and stress signals from sphingolipids (Huang et al., 2012). We found that Sch9p-T570 phosphorylation and total Sch9p are increased in ncr1Δ cells in a Pkh1p dependent manner. Importantly, deletion of either PKH1 or SCH9 suppressed oxidative stress sensitivity, shortened CLS and the mitochondrial dysfunction of ncr1Δ cells. However, the inhibition of de novo sphingolipid biosynthesis by treatment with myriocin did not increase the lifespan of ncr1Δ cells. This observation suggests that other changes in sphingolipid metabolism, rather than increased de novo biosynthesis, may lead to the accumulation of LCBs in ncr1Δ cells, e.g. through sphingolipid turnover mediated by Isc1p, an homologue of mammalian neutral sphingomyelinase, and/or ceramidases (Ypc1p or Ydc1p). Alternatively, LCB-Pkh1p-independent mechanisms may contribute to ncr1Δ phenotypes. Since Sch9p also can be phosphorylated in the C terminus by the target of rapamycin complex 1 (TORC1; Urban et al., 2007) and down-regulation of Sch9p mediates CLS extension associated with reduced TORC1 signaling (Pan & Shadel, 2009), deregulation of the TOR pathway may contribute to LCB-independent Sch9p-dependent phenotypes of ncr1Δ cells. How changes in sphingolipid dynamics or in TORC1 signaling contribute to ncr1Δ phenotypes is an important issue for future studies.
Moreover, autophagy is induced in NPC through a Beclin-1/class III PI3K complex-dependent mechanism (Pacheco et al., 2007), but the autophagic flux seems to be impaired (Ishibashi et al., 2009) due to the inhibition of cathepsin, a lysosomal protease, by stored lipids that leads to an impaired turnover of autolysosomes (Elrick et al., 2012). Notably, autophagy activation, associated with an impaired completion of autophagy, promotes lipid accumulation in the NPC lysosome and, therefore, disease pathogenesis (Elrick et al., 2012). In yeast, Ncr1p-deficient cells present an acidic shift of vacuolar pH that correlates with ergosterol accumulation in these organelles (Brett et al., 2011), which may also compromise the activity of vacuolar proteases. It was recently shown that myriocin enhances autophagy in yeast (Liu et al., 2013). Thus, the activation of autophagy by myriocin may be detrimental for ncr1Δ cells, preventing lifespan extension in this mutant.
The mechanisms underlying the phenotypes of ncr1Δ cells seem to be complex, with Sch9p also playing a role in mediating the changes in sphingolipid homeostasis measured in this mutant. Indeed, SCH9 deletion suppressed the high levels of LCBs displayed by ncr1Δ cells. More studies are needed to further characterize how Sch9p functions upstream in the regulation of sphingolipid metabolism, in addition to its role downstream as an effector of sphingolipid signaling. Nevertheless, other studies showed that sphingolipid homeostasis is regulated by an intricate network of protein kinases and protein phosphatases that can be activated by sphingolipids but also control sphingolipid biosynthesis, e.g. through modulation of Orm1/2p (Roelants et al., 2011, Liu et al., 2012, Sun et al., 2012, Shimobayashi et al., 2013).
In summary, our data show that the yeast model of NPC disease exhibits oxidative stress sensitivity and a shortened CLS associated with oxidative stress markers and mitochondrial fragmentation and dysfunction. In addition, our findings suggest that sphingolipid signaling mediated by the LCB-activated protein kinase Pkh1p and its downstream target Sch9p mediate ncr1Δ phenotypes. These results highlight the importance of oxidative stress and loss of mitochondria functionality in NPC and further support the use of yeast as a valuable model to study molecular mechanisms underlying the pathophysiology of NPC disease.
Experimental procedures
Yeast strains and growth conditions
The Saccharomyces cerevisiae strains used in this work are listed in table 1. The growth media used were YPD [1 % (w/v) yeast extract, 2 % (w/v) bactopeptone, 2 % (w/v) glucose], YPG [1 % (w/v) yeast extract, 2 % (w/v) bactopeptone, 4 % (v/v) glycerol], synthetic complete (SC) drop-out medium containing 2% (w/v) glucose 0.67% yeast nitrogen base without amino acids, or minimal medium containing 2% (w/v) glucose 0.67% yeast nitrogen base without amino acids, supplemented with appropriate amino acids [0.008 % (w/v) histidine, 0.04 % (w/v) leucine, 0.008 % (w/v) tryptophan)] or nucleotides (0.008 % (w/v) uracil). Yeast cells were grown aerobically at 26 ºC in an orbital shaker (at 140 r.p.m.), with a ratio of flask volume / medium volume of 5:1, to early exponential phase (OD600nm=0.6) or to post-diauxic phase (OD600nm=7–9). To generate ncr1Δ::KanMX4 cells, a deletion fragment containing KanMX4 and the flanking regions of NCR1 was amplified by polymerase chain reaction (PCR) using genomic DNA from S. cerevisiae BY4741 ncr1Δ cells (Euroscarf, Germany). Yeast cells were transformed by electroporation, and ncr1Δ mutant cells were selected in YPD containing 0.4 mg geneticin mL−1 (Sigma). To generate ncr1Δ::URA3 cells, the KanMX4 cassette in ncr1Δ::KanMX4 cells was replaced by URA3, using a deletion fragment containing an heterologous URA3 cassette and the flanking regions of KanMX4 that was amplified by PCR from pAG61 plasmid (Goldstein et al., 1999). The NCR1 gene was also disrupted in pkh1Δ and sch9Δ cells with a deletion fragment containing URA3 and the flanking regions of NCR1 that was amplified by PCR using genomic DNA from ncr1Δ::URA3 cells. Cells were selected in minimal medium lacking uracil and the correct integration of all cassettes was confirmed by PCR. For SOD2 and CTT1 overexpression, a BamHI fragment containing the SOD2 gene under its promotor and a HindIII-BamHI fragment containing the CTT1 gene under its promotor were cloned into YEp352. BY4741 and ncr1Δ::KanMX4 cells were transformed by electroporation with YEp352 (empty vector), YEp352-SOD2 and YEp352-CTT1 and selected in minimal medium lacking uracil.
Table 1.
Strain | Genotype | Reference/Source |
---|---|---|
BY4741*,¥ | Mata, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 | EUROSCARF |
ncr1Δ::KanMX4*,¥ | BY4741 ncr1Δ::KanMX4 | This study |
ncr1Δ::URA3 | BY4741 ncr1Δ::URA3 | This study |
sch9Δ* | BY4741 sch9D::KanMX4 | EUROSCARF |
ncr1Δsch9Δ* | BY4741 ncr1Δ::URA3 sch9Δ::KanMX4 | This study |
pkh1Δ* | BY4741 pkh1Δ::KanMX4 | EUROSCARF |
ncr1Δpkh1Δ* | BY4741 ncr1Δ::URA3 pkh1Δ::KanMX4 | This study |
Cells harboring pYX222-mtDsRed are indicated.
Cells harboring YEp352, YEp352-SOD2 and YEp352-CTT1 are indicated.
Oxidative stress resistance and chronological lifespan
For analysis of oxidative stress resistance, yeast cells were grown to exponential phase (OD600nm = 0.6) and treated with 1.5 mM H2O2 for 1 hour. Chronological lifespan was assayed as previously described (Mesquita et al., 2010). Briefly, overnight cultures were diluted to OD600nm=0.6 and grown for 24 hours (to PDS phase) or 48h (stationary phase; considered t0 in the lifespan assay) and kept in culture media at 26 ºC. Cell viability was determined by standard dilution plate counts on YPD medium containing 1.5 % (w/v) agar. Colonies were counted after growth for 3 days at 26 ºC. Viability was expressed as a percentage of colony-forming units in relation to time 0 or to untreated cells, as indicated. To analyze the effect of myriocin on CLS, yeast cells were treated as described previously (Huang et al., 2012) with minor modifications. A stock solution of 200 μg mL−1 myriocin (Sigma) was prepared in 95 % (v/v) ethanol. Cells were grown overnight and diluted to OD600nm=0.01. Then, 600 ng mL−1 myriocin or ethanol (vehicle; volume identical to myriocin) was added to the cultures. Cells were grown to stationary phase and cell viability was measured as described above.
Protein carbonylation, lipid peroxidation and intracellular oxidation
Protein oxidation was determined by immunodetection of protein carbonyls as previously described (Costa et al., 2002). Quantification of carbonyls was performed in a GS-800 densitometry (Bio-Rad). Lipid peroxidation was determined by quantification of thiobarbituric acid reactive substances as described (Belinha et al., 2007) and expressed as nmol MDA mg−1 protein. Levels of intracellular H2O2 and superoxide anion were detected with dihydrorhodamine (DHR) 123 and dihydroethidium (DHE) (Molecular Probes, Life Technologies), respectively. 3×107 cells were treated with 6 μL of DHR (stock solution at 2.5 mg mL−1; prepared in DMSO) and incubated for 60 minutes at 26 ºC, or with 1 μL of DHE (stock solution at 5 mM; prepared in DMSO) and incubated for 10 minutes at 26 ºC. Fluorescence of DHR-positive cells was measured on the FL-1 channel of a Becton Dickinson FACS Calibur Analytic Flow cytometer with excitation and emission settings of 488 nm and 515–545 nm, respectively, without compensation. The DHE staining was analyzed by flow cytometry with excitation and emission settings of 488 nm and ≥670 nm (FL3 channel) without compensation. The data was analyzed using the FlowJo software (Tree Star).
Glutathione levels and enzymatic activities
All the procedures were carried out at 4 ºC. Yeast cells were harvested by centrifugation. Glutathione levels were measured by the method of Tietze (1969), as described (Belinha et al., 2007), and expressed as μmol glutathione (mg protein) −1. For enzyme activities, yeast extracts were prepared in 50 mM potassium phosphate buffer (pH 7.0) containing protease inhibitors (Complete, Mini, EDTA-free Protease Cocktail Inhibitor Tablets; Roche Applied Science), as described (Almeida et al., 2008). The activity of catalase and SOD was determined spectrophotometrically (Aebi, 1984) (Beauchamp & Fridovich, 1971) or analyzed in situ, after separation of proteins (60 μg) by native PAGE, as described (Conyers & Kidwell, 1991, Flohe & Otting, 1984). Cytochrome c oxidase (COX) activity was determined as previously described (Poyton et al., 1995), by measuring cytochrome c oxidation.
Oxygen consumption and growth in glycerol
Oxygen consumption rate was measured for 3×108 cells at 26 ºC in phosphate buffer using an oxygen electrode (Oxygraph, Hansatech). Data were analyzed using the Oxyg32 v2.25 software. For analysis of respiratory capacity, yeast cells were grown to exponential phase (OD600nm = 0.6), diluted to an OD600nm = 0.1 and five-fold serial dilutions were plated in solid media containing glucose or glycerol as carbon source (YPD or YPG media supplemented with 1.5% (w/v) agar).
Mitochondrial fragmentation and mitochondrial membrane potential
Mitochondrial morphology was analyzed in cells transformed with a plasmid expressing mitochondrial DsRed (pYX222-mtDsRed). Cells were grown in SC-glucose medium lacking histidine to post-diauxic shift phase. The mitochondrial network was observed in live cells by fluorescence microscopy (AxioImager Z1, Carl Zeiss). Data image stacks were deconvolved by QMLE algorithm of Huygens Professional v3.0.2p1 (Scientific Volume Imaging B.V.). Maximum intensity projection was used to output final images using ImageJ 1.47n software. The mitochondrial membrane potential was measured by flow cytometry using cells probed with the potential-sensitive dye 3,3-dihexyloxacarbocyanine iodide [(DiOC6(3)], as described (Rottenberg & Wu, 1998). Briefly, 2×106 cells were re-suspended in suspension buffer [10 mM 2-(N-morpholino)ethanesulfonic acid (MES), 0.1 mM MgCl2 and 2 % (w/v) Glucose, pH 6.0] and DiOC6(3) (Invitrogen) was added to a final concentration of 1 nM. The cell suspension was then incubated for 30 minutes at 30 ºC and washed twice with PBS. The mitochondrial membrane potential was analyzed by flow cytometry (Becton-Dickinson FACS Calibur Analytic Flow Cytometer) on the FL1-channel with excitation and emission settings of 488 nm and 525 nm, respectively. The data was analyzed using the FlowJo software (Tree Star).
Sphingolipid analysis by HPLC-MS/MS
Yeast cells were grown in SC-glucose medium and 1.9×109 cells were collected at exponential and PDS phase. Cell pellets were re-suspended in 1ml of lipid extraction solvent: 50 % (v/v) iso-propanol, 10 % (v/v) diethyl ether, 2 % (v/v) pyridine, 25 % (v/v) ammonia. A 200 μl volume of glass beads were added into a screw cup 2 ml plastic tubes. Tubes were shaken in a bead better 5 times, 3 min on, 1 min off at 4°C. The content of the tubes was poured into a 13×100 mm glass tubes. An additional 1 ml solvent was used to wash the plastic tubes and was added into the glass tubes. The tubes containing 2 ml solvent with cells and glass beads were dried in an analytical nitrogen evaporator (N-EVAP). The dried samples were sent to the Lipidomic Core at the Medical University of South Carolina for lipid analysis. Levels of long-chain sphingoid bases and their phosphorylated forms were measured by the high-performance liquid chromatography/mass spectrometry (LC-MS/MS) methodology as previously described (Bielawski et al., 2010). Analytical results of lipids were expressed as pmol sphingolipid/ total cell number.
Protein extraction and western blotting analysis
Yeast cells were grown in SC-glucose medium to exponential or PDS phase and protein extracts were prepared as described (Huang et al., 2012) with minor modifications. Briefly, 9×108cells were collected, suspended in 200 μl of water and 200 μl of 0.2 M NaOH. Samples were vortexed and incubated at room temperature for 5 min, centrifuged and the pellet suspended in 200 μl of gel lysis buffer (50 mM Tris-HCl pH 8.8, 2 % (w/v) SDS, 10 % (v/v) glycerol, 2 mM EDTA). After heating 5 min at 95 ºC, samples were centrifuged and the protein content of the supernatant was quantified with BCATM Protein Assay Kit (Thermo Scientific) using bovine serum albumin as a standard. Proteins (30 μg) were mixed with 1 % (v/v) β-mercaptoethanol, heated for 2 min at 95 ºC, electrophoresed on a 9 % SDS-PAGE gel and transferred for 1.5 hours onto a nitrocellulose membrane (GE Healthcare). Each membrane was blocked in TTBS (20 mM Tris, 140 mM NaCl, 0.05 % (v/v) Tween-20 pH 7.6) containing 5 % nonfat dry milk. Membranes were then incubated with the primary antibody, mouse anti-yeast porin (Por1p) antibody (1:1000, Molecular Probes), mouse anti-yeast phosphoglycerate kinase (Pgk1p) antibody (1:40000, Molecular Probes), rabbit anti-Sch9p antibody (1:1000, kindly provided by Dr Robert Dickson) or rabbit anti-P-T570-Sch9p antibody (1:10000, kindly provided by Dr Robbie Loewith), and with the secondary antibody, anti-mouse IgG-peroxidase (1:5000, Molecular probes) or anti-rabbit IgG-peroxidase (1:5000, Sigma). Immunodetection was performed by chemiluminescence, using a kit from GE Healthcare (RPN 2109).
Statistical analysis
The results obtained were represented by mean and standard deviation values of at least three independent experiments. Statistical analyses were carried out using GraphPad Prism Software v6.02 (GraphPad Software).
Supplementary Material
Acknowledgments
This work was financially supported by FEDER (Fundo Europeu de Desenvolvimento Regional) through the program “Programa Operacional Fatores de Competitividade-COMPETE”, and by FCT (Fundação para a Ciência e Tecnologia) through the projects FCOMP-01-0124-FEDER-022718 (Pest-C/SAU/LA0002/2011) and NORTE-07-0124-FEDER-000001, and in part by National Institutes of Health Grant GM063265 (to Y. A. H.), the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313) and the Lipidomics Core in the SC Lipidomics and Pathobiology COBRE, Department Biochemistry, MUSC (P20 RR017677). R.V. (SFRH/BD/48125/2008) and V.T. (SFRH/BD/72134/2010) were supported by FCT fellowships. We are grateful to Paula Sampaio (ALM, IBMC) for the help with fluorescence microscopy, Catarina Leitão (AFCU, IBMC) for all the help with flow cytometry analysis, Paula Ludovico (ICVS, Universidade do Minho, Portugal) for providing the pYX222-mtDsRed plasmid, and Robert Dickson (University of Kentucky College of Medicine, Lexington, Kentucky, USA) and Robbie Loewith (University of Geneva, Switzerland) for providing antibodies used in this study.
Abbreviations
- CLS
chronological lifespan
- COX
cytochrome c oxidase
- DHE
dihydroethidium
- DHR
dihydrorhodamine
- DHS
dihydrosphingosine
- DNPH
2,4-dinitrophenylhydrazine
- MDA
malondialdehyde
- NPC
Niemann-Pick type C
- PDS
post-diauxic shift
- PHS
phytosphingosine
- PVDF
polyvinylidene difluoride
- ROS
reactive oxygen species
- SOD
superoxide dismutase
- TBARS
thiobarbituric acid reactive substances
Footnotes
Conflict of interests
The authors have no conflict of interest to declare.
References
- Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121–126. doi: 10.1016/s0076-6879(84)05016-3. [DOI] [PubMed] [Google Scholar]
- Almeida T, Marques M, Mojzita D, Amorim MA, Silva RD, Almeida B, Rodrigues P, Ludovico P, Hohmann S, Moradas-Ferreira P, Corte-Real M, Costa V. Isc1p plays a key role in hydrogen peroxide resistance and chronological lifespan through modulation of iron levels and apoptosis. Mol Biol Cell. 2008;19:865–876. doi: 10.1091/mbc.E07-06-0604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beauchamp C, Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem. 1971;44:276–287. doi: 10.1016/0003-2697(71)90370-8. [DOI] [PubMed] [Google Scholar]
- Belinha I, Amorim MA, Rodrigues P, de Freitas V, Moradas-Ferreira P, Mateus N, Costa V. Quercetin increases oxidative stress resistance and longevity in Saccharomyces cerevisiae. J Agric Food Chem. 2007;55:2446–2451. doi: 10.1021/jf063302e. [DOI] [PubMed] [Google Scholar]
- Berger AC, Hanson PK, Wylie Nichols J, Corbett AH. A yeast model system for functional analysis of the Niemann-Pick type C protein 1 homolog, Ncr1p. Traffic. 2005a;6:907–917. doi: 10.1111/j.1600-0854.2005.00327.x. [DOI] [PubMed] [Google Scholar]
- Berger AC, Vanderford TH, Gernert KM, Nichols JW, Faundez V, Corbett AH. Saccharomyces cerevisiae Npc2p is a functionally conserved homologue of the human Niemann-Pick disease type C 2 protein, hNPC2. Eukaryot Cell. 2005b;4:1851–1862. doi: 10.1128/EC.4.11.1851-1862.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bielawski J, Pierce JS, Snider J, Rembiesa B, Szulc ZM, Bielawska A. Sphingolipid analysis by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) Adv Exp Med Biol. 2010;688:46–59. doi: 10.1007/978-1-4419-6741-1_3. [DOI] [PubMed] [Google Scholar]
- Brett CL, Kallay L, Hua Z, Green R, Chyou A, Zhang Y, Graham TR, Donowitz M, Rao R. Genome-wide analysis reveals the vacuolar pH-stat of Saccharomyces cerevisiae. PLoS One. 2011;6:e17619. doi: 10.1371/journal.pone.0017619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, Gu J, Rosenfeld MA, Pavan WJ, Krizman DB, Nagle J, Polymeropoulos MH, Sturley SL, Ioannou YA, Higgins ME, Comly M, Cooney A, Brown A, Kaneski CR, Blanchette-Mackie EJ, Dwyer NK, Neufeld EB, Chang TY, Liscum L, Strauss JF, 3rd, Ohno K, Zeigler M, Carmi R, Sokol J, Markie D, O’Neill RR, van Diggelen OP, Elleder M, Patterson MC, Brady RO, Vanier MT, Pentchev PG, Tagle DA. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science. 1997;277:228–231. doi: 10.1126/science.277.5323.228. [DOI] [PubMed] [Google Scholar]
- Charman M, Kennedy BE, Osborne N, Karten B. MLN64 mediates egress of cholesterol from endosomes to mitochondria in the absence of functional Niemann-Pick Type C1 protein. J Lipid Res. 2010;51:1023–1034. doi: 10.1194/jlr.M002345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cologna SM, Jiang XS, Backlund PS, Cluzeau CV, Dail MK, Yanjanin NM, Siebel S, Toth CL, Jun HS, Wassif CA, Yergey AL, Porter FD. Quantitative proteomic analysis of Niemann-Pick disease, type C1 cerebellum identifies protein biomarkers and provides pathological insight. PLoS One. 2012;7:e47845. doi: 10.1371/journal.pone.0047845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Conyers SM, Kidwell DA. Chromogenic substrates for horseradish peroxidase. Anal Biochem. 1991;192:207–211. doi: 10.1016/0003-2697(91)90208-b. [DOI] [PubMed] [Google Scholar]
- Costa V, Amorim MA, Quintanilha A, Moradas-Ferreira P. Hydrogen peroxide-induced carbonylation of key metabolic enzymes in Saccharomyces cerevisiae: the involvement of the oxidative stress response regulators Yap1 and Skn7. Free Radical Biology and Medicine. 2002;33:1507–1515. doi: 10.1016/s0891-5849(02)01086-9. [DOI] [PubMed] [Google Scholar]
- Costa V, Moradas-Ferreira P. Oxidative stress and signal transduction in Saccharomyces cerevisiae: insights into ageing, apoptosis and diseases. Molecular Aspects of Medicine. 2001;22:217–246. doi: 10.1016/s0098-2997(01)00012-7. [DOI] [PubMed] [Google Scholar]
- de la Torre-Ruiz MA, Mozo-Villarias A, Pujol N, Petkova MI. How budding yeast sense and transduce the oxidative stress signal and the impact in cell growth and morphogenesis. Curr Protein Pept Sci. 2010;11:669–679. doi: 10.2174/138920310794557628. [DOI] [PubMed] [Google Scholar]
- De Windt A, Rai M, Kytomaki L, Thelen KM, Lutjohann D, Bernier L, Davignon J, Soini J, Pandolfo M, Laaksonen R. Gene set enrichment analyses revealed several affected pathways in Niemann-pick disease type C fibroblasts. DNA Cell Biol. 2007;26:665–671. doi: 10.1089/dna.2006.0570. [DOI] [PubMed] [Google Scholar]
- Elrick MJ, Yu T, Chung C, Lieberman AP. Impaired proteolysis underlies autophagic dysfunction in Niemann-Pick type C disease. Hum Mol Genet. 2012;21:4876–4887. doi: 10.1093/hmg/dds324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fabrizio P, Longo VD. The chronological life span of Saccharomyces cerevisiae. Aging Cell. 2003;2:73–81. doi: 10.1046/j.1474-9728.2003.00033.x. [DOI] [PubMed] [Google Scholar]
- Fabrizio P, Pozza F, Pletcher SD, Gendron CM, Longo VD. Regulation of longevity and stress resistance by Sch9 in yeast. Science. 2001;292:288–290. doi: 10.1126/science.1059497. [DOI] [PubMed] [Google Scholar]
- Farrugia G, Balzan R. Oxidative stress and programmed cell death in yeast. Front Oncol. 2012;2:64. doi: 10.3389/fonc.2012.00064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Flohe L, Otting F. Superoxide dismutase assays. Methods Enzymol. 1984;105:93–104. doi: 10.1016/s0076-6879(84)05013-8. [DOI] [PubMed] [Google Scholar]
- Goez HR, Jacob FD, Fealey RD, Patterson MC, Ramaswamy V, Persad R, Johnson ES, Yager JY. An unusual presentation of copper metabolism disorder and a possible connection with Niemann-Pick type C. J Child Neurol. 2011;26:518–521. doi: 10.1177/0883073810383983. [DOI] [PubMed] [Google Scholar]
- Goldstein AL, Pan X, McCusker JH. Heterologous URA3MX cassettes for gene replacement in Saccharomyces cerevisiae. Yeast. 1999;15:507–511. doi: 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
- Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol. 2008;9:139–150. doi: 10.1038/nrm2329. [DOI] [PubMed] [Google Scholar]
- Henderson LM, Chappell JB. Dihydrorhodamine 123: a fluorescent probe for superoxide generation? Eur J Biochem. 1993;217:973–980. doi: 10.1111/j.1432-1033.1993.tb18328.x. [DOI] [PubMed] [Google Scholar]
- Huang X, Liu J, Dickson RC. Down-regulating sphingolipid synthesis increases yeast lifespan. PLoS Genet. 2012;8:e1002493. doi: 10.1371/journal.pgen.1002493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ikonen E, Holtta-Vuori M. Cellular pathology of Niemann-Pick type C disease. Semin Cell Dev Biol. 2004;15:445–454. doi: 10.1016/j.semcdb.2004.03.001. [DOI] [PubMed] [Google Scholar]
- Ishibashi S, Yamazaki T, Okamoto K. Association of autophagy with cholesterol-accumulated compartments in Niemann-Pick disease type C cells. J Clin Neurosci. 2009;16:954–959. doi: 10.1016/j.jocn.2008.09.020. [DOI] [PubMed] [Google Scholar]
- Ko DC, Binkley J, Sidow A, Scott MP. The integrity of a cholesterol-binding pocket in Niemann-Pick C2 protein is necessary to control lysosome cholesterol levels. Proc Natl Acad Sci U S A. 2003;100:2518–2525. doi: 10.1073/pnas.0530027100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kwon HJ, Abi-Mosleh L, Wang ML, Deisenhofer J, Goldstein JL, Brown MS, Infante RE. Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell. 2009;137:1213–1224. doi: 10.1016/j.cell.2009.03.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Laschober GT, Ruli D, Hofer E, Muck C, Carmona-Gutierrez D, Ring J, Hutter E, Ruckenstuhl C, Micutkova L, Brunauer R, Jamnig A, Trimmel D, Herndler-Brandstetter D, Brunner S, Zenzmaier C, Sampson N, Breitenbach M, Frohlich KU, Grubeck-Loebenstein B, Berger P, Wieser M, Grillari-Voglauer R, Thallinger GG, Grillari J, Trajanoski Z, Madeo F, Lepperdinger G, Jansen-Durr P. Identification of evolutionarily conserved genetic regulators of cellular aging. Aging Cell. 2010;9:1084–1097. doi: 10.1111/j.1474-9726.2010.00637.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lavoie H, Whiteway M. Increased respiration in the sch9Delta mutant is required for increasing chronological life span but not replicative life span. Eukaryot Cell. 2008;7:1127–1135. doi: 10.1128/EC.00330-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu J, Huang X, Withers BR, Blalock E, Liu K, Dickson RC. Reducing sphingolipid synthesis orchestrates global changes to extend yeast lifespan. Aging Cell. 2013;12:833–841. doi: 10.1111/acel.12107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu JP, Tang Y, Zhou S, Toh BH, McLean C, Li H. Cholesterol involvement in the pathogenesis of neurodegenerative diseases. Mol Cell Neurosci. 2010;43:33–42. doi: 10.1016/j.mcn.2009.07.013. [DOI] [PubMed] [Google Scholar]
- Liu K, Zhang X, Lester RL, Dickson RC. The sphingoid long chain base phytosphingosine activates AGC-type protein kinases in Saccharomyces cerevisiae including Ypk1, Ypk2, and Sch9. J Biol Chem. 2005;280:22679–22687. doi: 10.1074/jbc.M502972200. [DOI] [PubMed] [Google Scholar]
- Liu M, Huang C, Polu SR, Schneiter R, Chang A. Regulation of sphingolipid synthesis through Orm1 and Orm2 in yeast. J Cell Sci. 2012;125:2428–2435. doi: 10.1242/jcs.100578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lloyd-Evans E, Morgan AJ, He X, Smith DA, Elliot-Smith E, Sillence DJ, Churchill GC, Schuchman EH, Galione A, Platt FM. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat Med. 2008;14:1247–1255. doi: 10.1038/nm.1876. [DOI] [PubMed] [Google Scholar]
- Lloyd-Evans E, Platt FM. Lysosomal Ca (2+) homeostasis: role in pathogenesis of lysosomal storage diseases. Cell Calcium. 2011;50:200–205. doi: 10.1016/j.ceca.2011.03.010. [DOI] [PubMed] [Google Scholar]
- Longo VD. The Ras and Sch9 pathways regulate stress resistance and longevity. Exp Gerontol. 2003;38:807–811. doi: 10.1016/s0531-5565(03)00113-x. [DOI] [PubMed] [Google Scholar]
- Longo VD, Shadel GS, Kaeberlein M, Kennedy B. Replicative and chronological aging in Saccharomyces cerevisiae. Cell Metab. 2012;16:18–31. doi: 10.1016/j.cmet.2012.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Malathi K, Higaki K, Tinkelenberg AH, Balderes DA, Almanzar-Paramio D, Wilcox LJ, Erdeniz N, Redican F, Padamsee M, Liu Y, Khan S, Alcantara F, Carstea ED, Morris JA, Sturley SL. Mutagenesis of the putative sterol-sensing domain of yeast Niemann Pick C-related protein reveals a primordial role in subcellular sphingolipid distribution. J Cell Biol. 2004;164:547–556. doi: 10.1083/jcb.200310046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martinez MJ, Roy S, Archuletta AB, Wentzell PD, Anna-Arriola SS, Rodriguez AL, Aragon AD, Quinones GA, Allen C, Werner-Washburne M. Genomic analysis of stationary-phase and exit in Saccharomyces cerevisiae: gene expression and identification of novel essential genes. Mol Biol Cell. 2004;15:5295–5305. doi: 10.1091/mbc.E03-11-0856. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mesquita A, Weinberger M, Silva A, Sampaio-Marques B, Almeida B, Leao C, Costa V, Rodrigues F, Burhans WC, Ludovico P. Caloric restriction or catalase inactivation extends yeast chronological lifespan by inducing H2O2 and superoxide dismutase activity. Proc Natl Acad Sci U S A. 2010;107:15123–15128. doi: 10.1073/pnas.1004432107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Munkacsi AB, Chen FW, Brinkman MA, Higaki K, Gutierrez GD, Chaudhari J, Layer JV, Tong A, Bard M, Boone C, Ioannou YA, Sturley SL. An “exacerbate-reverse” strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann-Pick type C disease. J Biol Chem. 2011;286:23842–23851. doi: 10.1074/jbc.M111.227645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417:1–13. doi: 10.1042/BJ20081386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Naureckiene S, Sleat DE, Lackland H, Fensom A, Vanier MT, Wattiaux R, Jadot M, Lobel P. Identification of HE1 as the second gene of Niemann-Pick C disease. Science. 2000;290:2298–2301. doi: 10.1126/science.290.5500.2298. [DOI] [PubMed] [Google Scholar]
- Ordonez MP, Roberts EA, Kidwell CU, Yuan SH, Plaisted WC, Goldstein LS. Disruption and therapeutic rescue of autophagy in a human neuronal model of Niemann Pick type C1. Hum Mol Genet. 2012;21:2651–2662. doi: 10.1093/hmg/dds090. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pacheco CD, Kunkel R, Lieberman AP. Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects. Hum Mol Genet. 2007;16:1495–1503. doi: 10.1093/hmg/ddm100. [DOI] [PubMed] [Google Scholar]
- Pan Y. Mitochondria, reactive oxygen species, and chronological aging: a message from yeast. Exp Gerontol. 2011;46:847–852. doi: 10.1016/j.exger.2011.08.007. [DOI] [PubMed] [Google Scholar]
- Pan Y, Shadel GS. Extension of chronological life span by reduced TOR signaling requires down-regulation of Sch9p and involves increased mitochondrial OXPHOS complex density. Aging (Albany NY) 2009;1:131–145. doi: 10.18632/aging.100016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pedruzzi I, Dubouloz F, Cameroni E, Wanke V, Roosen J, Winderickx J, De Virgilio C. TOR and PKA signaling pathways converge on the protein kinase Rim15 to control entry into G0. Mol Cell. 2003;12:1607–1613. doi: 10.1016/s1097-2765(03)00485-4. [DOI] [PubMed] [Google Scholar]
- Pentchev PG, Brady RO, Blanchette-Mackie EJ, Vanier MT, Carstea ED, Parker CC, Goldin E, Roff CF. The Niemann-Pick C lesion and its relationship to the intracellular distribution and utilization of LDL cholesterol. Biochim Biophys Acta. 1994;1225:235–243. doi: 10.1016/0925-4439(94)90001-9. [DOI] [PubMed] [Google Scholar]
- Pineda M, Perez-Poyato MS, O’Callaghan M, Vilaseca MA, Pocovi M, Domingo R, Portal LR, Perez AV, Temudo T, Gaspar A, Penas JJ, Roldan S, Fumero LM, de la Barca OB, Silva MT, Macias-Vidal J, Coll MJ. Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case series. Mol Genet Metab. 2010;99:358–366. doi: 10.1016/j.ymgme.2009.11.007. [DOI] [PubMed] [Google Scholar]
- Poyton RO, Goehring B, Droste M, Sevarino KA, Allen LA, Zhao XJ. Cytochrome-c oxidase from Saccharomyces cerevisiae. Methods Enzymol. 1995;260:97–116. doi: 10.1016/0076-6879(95)60133-3. [DOI] [PubMed] [Google Scholar]
- Reddy JV, I, Ganley G, Pfeffer SR. Clues to neuro-degeneration in Niemann-Pick Type C disease from global gene expression profiling. PLoS One. 2006;1:e19. doi: 10.1371/journal.pone.0000019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roelants FM, Breslow DK, Muir A, Weissman JS, Thorner J. Protein kinase Ypk1 phosphorylates regulatory proteins Orm1 and Orm2 to control sphingolipid homeostasis in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 2011;108:19222–19227. doi: 10.1073/pnas.1116948108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roelants FM, Torrance PD, Thorner J. Differential roles of PDK1- and PDK2-phosphorylation sites in the yeast AGC kinases Ypk1, Pkc1 and Sch9. Microbiology. 2004;150:3289–3304. doi: 10.1099/mic.0.27286-0. [DOI] [PubMed] [Google Scholar]
- Roosen J, Engelen K, Marchal K, Mathys J, Griffioen G, Cameroni E, Thevelein JM, De Virgilio C, De Moor B, Winderickx J. PKA and Sch9 control a molecular switch important for the proper adaptation to nutrient availability. Mol Microbiol. 2005;55:862–880. doi: 10.1111/j.1365-2958.2004.04429.x. [DOI] [PubMed] [Google Scholar]
- Rottenberg H, Wu S. Quantitative assay by flow cytometry of the mitochondrial membrane potential in intact cells. Biochim Biophys Acta. 1998;1404:393–404. doi: 10.1016/s0167-4889(98)00088-3. [DOI] [PubMed] [Google Scholar]
- Santangelo GM. Glucose signaling in Saccharomyces cerevisiae. Microbiol Mol Biol Rev. 2006;70:253–282. doi: 10.1128/MMBR.70.1.253-282.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schedin S, Sindelar PJ, Pentchev P, Brunk U, Dallner G. Peroxisomal impairment in Niemann-Pick type C disease. J Biol Chem. 1997;272:6245–6251. doi: 10.1074/jbc.272.10.6245. [DOI] [PubMed] [Google Scholar]
- Shen D, Wang X, Li X, Zhang X, Yao Z, Dibble S, Dong XP, Yu T, Lieberman AP, Showalter HD, Xu H. Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release. Nat Commun. 2012;3:731. doi: 10.1038/ncomms1735. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shimobayashi M, Oppliger W, Moes S, Jeno P, Hall MN. TORC1-regulated protein kinase Npr1 phosphorylates Orm to stimulate complex sphingolipid synthesis. Mol Biol Cell. 2013;24:870–881. doi: 10.1091/mbc.E12-10-0753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sleat DE, Wiseman JA, El-Banna M, Price SM, Verot L, Shen MM, Tint GS, Vanier MT, Walkley SU, Lobel P. Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proc Natl Acad Sci U S A. 2004;101:5886–5891. doi: 10.1073/pnas.0308456101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sun Y, Miao Y, Yamane Y, Zhang C, Shokat KM, Takematsu H, Kozutsumi Y, Drubin DG. Orm protein phosphoregulation mediates transient sphingolipid biosynthesis response to heat stress via the Pkh-Ypk and Cdc55-PP2A pathways. Mol Biol Cell. 2012;23:2388–2398. doi: 10.1091/mbc.E12-03-0209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969;27:502–522. doi: 10.1016/0003-2697(69)90064-5. [DOI] [PubMed] [Google Scholar]
- Urban J, Soulard A, Huber A, Lippman S, Mukhopadhyay D, Deloche O, Wanke V, Anrather D, Ammerer G, Riezman H, Broach JR, De Virgilio C, Hall MN, Loewith R. Sch9 is a major target of TORC1 in Saccharomyces cerevisiae. Mol Cell. 2007;26:663–674. doi: 10.1016/j.molcel.2007.04.020. [DOI] [PubMed] [Google Scholar]
- Vanier MT. Lipid Changes in Niemann-Pick Disease Type C Brain: Personal Experience and Review of the Literature. Neurochemical Research. 1999;24:481–489. doi: 10.1023/a:1022575511354. [DOI] [PubMed] [Google Scholar]
- Vanier MT. Niemann-Pick disease type C. Orphanet J Rare Dis. 2010;5:16. doi: 10.1186/1750-1172-5-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vanier MT, Millat G. Structure and function of the NPC2 protein. Biochim Biophys Acta. 2004;1685:14–21. doi: 10.1016/j.bbalip.2004.08.007. [DOI] [PubMed] [Google Scholar]
- Vazquez MC, Balboa E, Alvarez AR, Zanlungo S. Oxidative stress: a pathogenic mechanism for Niemann-Pick type C disease. Oxid Med Cell Longev. 2012;2012:205713. doi: 10.1155/2012/205713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vazquez MC, del Pozo T, Robledo FA, Carrasco G, Pavez L, Olivares F, Gonzalez M, Zanlungo S. Alteration of gene expression profile in Niemann-Pick type C mice correlates with tissue damage and oxidative stress. PLoS One. 2011;6:e28777. doi: 10.1371/journal.pone.0028777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Voordeckers K, Kimpe M, Haesendonckx S, Louwet W, Versele M, Thevelein JM. Yeast 3-phosphoinositide-dependent protein kinase-1 (PDK1) orthologs Pkh1–3 differentially regulate phosphorylation of protein kinase A (PKA) and the protein kinase B (PKB)/S6K ortholog Sch9. J Biol Chem. 2011;286:22017–22027. doi: 10.1074/jbc.M110.200071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walkley SU, Suzuki K. Consequences of NPC1 and NPC2 loss of function in mammalian neurons. Biochim Biophys Acta. 2004;1685:48–62. doi: 10.1016/j.bbalip.2004.08.011. [DOI] [PubMed] [Google Scholar]
- Wraith JE, Imrie J. New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat. Ther Clin Risk Manag. 2009;5:877–887. doi: 10.2147/tcrm.s5777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wu Z, Liu SQ, Huang D. Dietary restriction depends on nutrient composition to extend chronological lifespan in budding yeast Saccharomyces cerevisiae. PLoS One. 2013;8:e64448. doi: 10.1371/journal.pone.0064448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xu M, Liu K, Swaroop M, Porter FD, Sidhu R, Finkes S, Ory DS, Marugan JJ, Xiao J, Southall N, Pavan WJ, Davidson C, Walkley SU, Remaley AT, Baxa U, Sun W, McKew JC, Austin CP, Zheng W. delta-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disorders. J Biol Chem. 2012;287:39349–39360. doi: 10.1074/jbc.M112.357707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yu W, Gong JS, Ko M, Garver WS, Yanagisawa K, Michikawa M. Altered cholesterol metabolism in Niemann-Pick type C1 mouse brains affects mitochondrial function. J Biol Chem. 2005;280:11731–11739. doi: 10.1074/jbc.M412898200. [DOI] [PubMed] [Google Scholar]
- Zampieri S, Mellon SH, Butters TD, Nevyjel M, Covey DF, Bembi B, Dardis A. Oxidative stress in NPC1 deficient cells: protective effect of allopregnanolone. J Cell Mol Med. 2009;13:3786–3796. doi: 10.1111/j.1582-4934.2008.00493.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang S, Ren J, Li H, Zhang Q, Armstrong JS, Munn AL, Yang H. Ncr1p, the yeast ortholog of mammalian Niemann Pick C1 protein, is dispensable for endocytic transport. Traffic. 2004;5:1017–1030. doi: 10.1111/j.1600-0854.2004.00241.x. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.